Baker McKenzie advised Eurazeo Capital, a French global investment company, on the acquisition of DORC Group (Dutch Ophthalmic Research Center).
Established in 1983 and headquartered in the Netherlands, DORC operates in the medical technology sector and is one of the global leading specialists of vitreoretinal surgery. DORC designs, manufactures and distributes ophthalmic surgery equipment, consumables and instruments. The company serves over 5,700 surgeons and is recognised for its strong innovation capability. DORC is a global company with a presence across 80 countries and enjoys strong market shares in Europe. DORC has more than 500 employees worldwide.
A cross-border Baker McKenzie team provided comprehensive advice on all legal aspects of the transaction. The team consisted of Matthieu Grollemund (Paris), Antoine Caillard (Paris), Martine van de Laar (Amsterdam), Auriane Wessels (Paris) and Beau Visser (Amsterdam).